SCHEMBL6629035

SCHEMBL6629035

COc1ccc(-c2csc(-c3cnccc3-c3ccccc3)n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.65
MAPT P10636 7/20 0.57
KDM4E B2RXH2 6/20 0.57
RAB9A P51151 6/20 0.57
SMN1; SMN2 Q16637 5/20 0.57
NPC1 O15118 4/20 0.57
CYP1A1 P04798 2/20 0.56
CYP1B1 Q16678 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
KMT2A Q03164 6/20 0.54
AR P10275 1/20 0.54
ALDH1A1 P00352 5/20 0.53
ATM Q13315 2/20 0.53
POLB P06746 1/20 0.53
MEN1 O00255 5/20 0.51
NFKB1 P19838 3/20 0.51
NFKB2 Q00653 3/20 0.51
RELA Q04206 3/20 0.51
LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648655 0.87 KDM4E (0.71) CYP19A1KDM4ERAB9ASMN1; SMN2NPC1
SCHEMBL6693465 0.82 MAPT (0.75) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL12443403 0.82 CYP19A1 (0.90) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL13458065 0.81 MAPT (0.73) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL6628490 0.80 CYP19A1 (0.58) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL4279334 0.80 KDM4E (0.75) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL6649613 0.79 CYP19A1 (0.59) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL6628492 0.79 SREBF2 (0.61) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL6646512 0.78 MAPT (0.55) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL6648628 0.78 CYP19A1 (0.60) CYP19A1MAPTKDM4ERAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432706-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027085-A2 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed